- active not recruitingPHASE2
A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
This study is testing a new medicine, Enicepatide, for people who have type 2 diabetes and are overweight or obese. Researchers want to see if it helps with blood sugar and weight, and if it's safe. Some people will get the new medicine, others will get a dummy medicine (placebo).
United States · Argentina · Canada - recruitingPHASE1
A Phase 1b Study of QX1206 in T2DM Patients With NAFLD
This study is looking at a new drug, QX1206, for people with type 2 diabetes and fatty liver disease. It aims to find the right dose and see if it helps improve their health.
Canada - ongoing, recruitingTherapeutic confirmatory (Phase III)
A Multicentre, Randomized, Double-blind, Placebo-controlled, phase III study to evaluate the efficacy and safety of Pioglitazone co-administration in patients with type II diabetes with insufficient glycemic control with Metformin and Empagliflozin combination therapy
This study is looking at a new way to treat Type 2 diabetes. It aims to see if adding an extra medication, Pioglitazone, to a common treatment (Metformin and Empagliflozin) helps people manage their blood sugar better. It also checks if this new combination is safe.
Poland - completedNot Applicable
Improving glucose control for patients with diabetes undergoing surgery
This study looks at using a continuous glucose monitor (a patch) for people with type 2 diabetes having surgery. We want to see if it helps manage blood sugar better and if patients and staff find it easy to use before a larger study begins.
United Kingdom · England - enrolling by invitationNA
Validation of the Snouda Metabolic Score for Phenotyping and Guiding Reversal in Type 2 Diabetes
This study tests a new tool called the Snouda Metabolic Score to personalise Type 2 Diabetes treatment. It aims to see if tailoring diet, exercise, and supplements to individual metabolic needs can help people achieve remission.
United Kingdom - ongoing, recruitingTherapeutic use (Phase IV)
Pan-European proof-of-concept study comparing Decentralised Clinical Trial (DCT) and hybrid approaches to conventional clinical trial approaches in patients with Type 2 diabetes mellitus treated with Toujeo®
This study is looking at new ways to run clinical trials for people with Type 2 diabetes who use Toujeo insulin. It compares traditional trial methods with more flexible approaches to see which works best for patients.
Denmark · Italy · Spain - not yet recruitingNA
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
This study in France looks at how blood vessels work in people with or at risk of kidney disease. It uses two new non-invasive devices, HEMI and SPG-NINOX, to check tiny blood vessels. The goal is to understand changes linked to heart, metabolism, and kidney problems.
France - recruitingNA
Feasibility of a Tailored Online Self-compassion Intervention
This study looks at an online self-compassion program for people with type 1 or type 2 diabetes. It aims to see if the program can help reduce distress, self-criticism, and shame, and improve health by teaching new ways to cope with their condition.
United Kingdom